Skyhawk Therapeutics
The Clinical Scientist will provide strategic and hands‑on medical leadership for neuroscience and orphan disease clinical development programs, shaping strategy from translational readiness through early and mid‑stage execution. The role integrates disease biology, biomarker strategies, study design, safety monitoring, and evidence generation while collaborating with cross‑functional teams and external partners.
Headquarters
Waltham, Massachusetts, United States
Company Size
51-200 employees
Founded
2016
Skyhawk Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing RNA-targeting small molecules to treat serious diseases. Its SKYSTAR platform enables rapid discovery of RNA-modulating compounds across neurology, oncology, and fibrotic diseases, with programs such as SKY-0515 for Huntington's disease and collaborations with major pharmaceutical partners.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Skyhawk Therapeutics.
Skyhawk Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Senior Principal Scientist, Neuroscience, Clinical Biomarker, Late Phases, Translational Medicine
Bristol Myers Squibb
Principal Scientist
Merck & Co., Inc.
Principal Scientist
Merck & Co., Inc.
Principal Scientist
Merck & Co., Inc.
Scientific Director II, Translational Precision Medicine, Neuroscience
AbbVie
Senior Principal Scientist, Cardiovascular, Translational Development
Bristol Myers Squibb